TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
SBM Life Science AB
Closing information (x1000 EUR)
| Closing information | 2024/09 | 2023/09 | 2022/09 |
| Turnover |
17,549
|
15,658
|
19,626 |
| Financial expenses |
286
|
528
|
486 |
| Earnings before taxes |
66
|
-118
|
386 |
| EBITDA |
351
|
334
|
823 |
| Total assets |
10,857
|
9,118
|
15,275 |
| Current assets |
10,786
|
9,025
|
15,186 |
| Current liabilities |
9,335
|
7,672
|
13,637 |
| Equity capital |
1,522
|
1,447
|
1,638 |
| - share capital |
4
|
4
|
5 |
| Employees (average) |
15
|
18
|
19 |
Financial ratios
| Fiscal year | 2024/09 | 2023/09 | 2022/09 |
| Solvency |
14.0%
|
15.9%
|
10.7% |
| Turnover per employee |
1,170
|
870
|
1,033 |
| Profit as a percentage of turnover |
0.4%
|
-0.8%
|
2.0% |
| Return on assets (ROA) |
3.2%
|
4.5%
|
5.7% |
| Current ratio |
115.5%
|
117.6%
|
111.4% |
| Return on equity (ROE) |
4.3%
|
-8.2%
|
23.6% |
| Change turnover |
1,624
|
-2,987
|
1,034 |
| Change turnover % |
10%
|
-16%
|
6% |
| Chg. No. of employees |
-3
|
-1
|
-8 |
| Chg. No. of employees % |
-17%
|
-5%
|
-30% |
Total value of public sale
| Fiscal year | 2024/09 | 2023/09 | 2022/09 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.